Then, we integrated the EMT-LN signature and C3orf70 mutation to generate a nomogram, which allowed the clinicians to predict LN metastasis risk in patients with BLCA preoperatively. The gene discussed is C3orf70; the disease is bladder transitional cell carcinoma.